Potential utility of an expression array signature for predicting anthracycline responsiveness or resistance.
Michael F
MF
Press
Michael A
MA
Gordon
Dennis J
DJ
Slamon
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D019008:Drug Resistance, Neoplasm; D015251:Epirubicin / Q000627:therapeutic use*; D005260:Female; D006801:Humans
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin